Abdallah S. Daar

ORCID: 0000-0002-0251-1352
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Biotechnology and Related Fields
  • Biomedical Ethics and Regulation
  • CRISPR and Genetic Engineering
  • Organ Donation and Transplantation
  • Biomedical and Engineering Education
  • Organ Transplantation Techniques and Outcomes
  • Genetics, Bioinformatics, and Biomedical Research
  • Ethics in medical practice
  • Ethics in Clinical Research
  • Science, Research, and Medicine
  • Pharmaceutical Economics and Policy
  • Intellectual Property and Patents
  • Genetically Modified Organisms Research
  • Global Health and Surgery
  • Innovation and Socioeconomic Development
  • Pluripotent Stem Cells Research
  • Global Public Health Policies and Epidemiology
  • Xenotransplantation and immune response
  • Nutrition, Genetics, and Disease
  • Health Systems, Economic Evaluations, Quality of Life
  • Organ and Tissue Transplantation Research
  • Renal Transplantation Outcomes and Treatments
  • BRCA gene mutations in cancer
  • Genomics and Rare Diseases
  • Pharmaceutical industry and healthcare

University of Toronto
2011-2023

Stellenbosch University
2013-2023

Public Health Ontario
2009-2018

University Health Network
2005-2015

Centre for Global Health Research
2006-2014

Queensland University of Technology
2012

MaRS
2010

National Institute of Advanced Industrial Science and Technology
2010

Dankook University
2010

Health Canada
2009

Health (GCGH) initiative, discussed in the fi rst article this series [3], we are exploring a range of ESC issues identifi ed by GCGH investigators and developing world key informants, second [4]. The informants placed particular emphasis upon importance community engagement, therefore prepared conceptual paper on topic, which distributed as working to program staff at 2nd Annual Meeting. In article, summarize paper. We examine concept CE research countries, then describe published models...

10.1371/journal.pmed.0040273 article EN cc-by PLoS Medicine 2007-09-07

A Defi nition of NanotechnologyNanotechnology is the study, design, creation, synthesis, manipulation, and application functional materials, devices, systems through control matter at nanometer scale (1-100 nanometers, one being equal to 1 × 10 -9 a meter), that is, atomic molecular levels, exploitation novel phenomena properties scale.

10.1371/journal.pmed.0020097 article EN cc-by PLoS Medicine 2005-04-04

This is one article in a five-part series providing global perspective on integrating mental health.The Policy Forum allows health policy makers around the world to discuss challenges and opportunities for improving care their societies.

10.1371/journal.pmed.1001434 article EN cc-by PLoS Medicine 2013-04-30

Nanotechnology (NT) is a rapidly progressing field. Advances will have tremendous impact on fields such as materials, electronics, and medicine. A thorough review of the current literature, governmental funding, policy documents was undertaken. Despite potential NT, abundance funds, our research revealed that there paucity serious, published into ethical, legal, social implications NT. As science leaps ahead, ethics lags behind. There danger derailing NT if study does not catch up with speed...

10.1088/0957-4484/14/3/201 article EN Nanotechnology 2003-02-13

This week an international panel announces a list of 14 Grand Challenges in Global Health, and scientists throughout the world will be invited to submit grant proposals pursue them with funds provided by Bill Melinda Gates Foundation. We describe characteristics these challenges process which they were formulated selected after receiving over 1000 responses "call for ideas" from scientific community.

10.1126/science.1091769 article EN Science 2003-10-16

Despite spectacular twentieth century scientific and technological progress, the world is more inequitable than it was fifty years ago. This evident both in terms of access to health care for individuals, relation whole populations. Disparities wealth within between nations are widening inexorably rapidly expanding global economy has failed reduce poverty among those with little if any care. In this context Universal Declaration Human Rights remains an unrealized aspiration majority world's...

10.1111/1468-2346.00298 article EN International Affairs 2003-01-01

In the third article of a five-part series providing global perspective on integrating mental health, Victoria Ngo and colleagues discuss benefits requirements collaborative care models, where non-communicable disease health are integrated provided in primary setting. Please see later for Editors' Summary

10.1371/journal.pmed.1001443 article EN cc-by PLoS Medicine 2013-05-14

There exists a lack of consensus regarding clear and precise definition regenerative medicine. We suggest here developed by the authors with input from researchers in various contributing disciplines. This emphasizes interdisciplinarity field, its goal restoring impaired function, wide variety technologies that can contribute to achieving this goal. By highlighting agreement medicine, proposing our own definition, we hope stimulate discussion on subject within field encourage medicine...

10.1002/term.20 article EN Journal of Tissue Engineering and Regenerative Medicine 2007-01-01

Genetic databases are becoming increasingly common as a means of determining the relationship between lifestyle, environmental exposures and genetic diseases. These rely on large numbers research subjects contributing their material to successfully explore basis disease. However, all possible questions that can be posed data unknown, an unresolved ethical issue is status informed consent for future uses material.In this paper, we discuss difficulties model ineffable data. We argue variations...

10.1186/1472-6939-4-1 article EN cc-by BMC Medical Ethics 2003-01-03

Benatar and colleagues argue that the world has changed profoundly since birth of modern bioethics in 1960s, needs to address today's global health problems.

10.1371/journal.pmed.0020143 article EN cc-by PLoS Medicine 2005-07-14

Abstract The use of race in biomedical research has, for decades, been a source social controversy. However, recent events, such as the adoption racially targeted pharmaceuticals, have raised profile issue. In addition, we are entering an era which genomic is increasingly focused on nature and extent human genetic variation, often examined by population, leads to heightened potential misunderstandings or misuse terms concerning variation race. Here, draw together perspectives participants...

10.1186/gm8 article EN cc-by Genome Medicine 2009-01-21

The poor in low and middle income countries have limited access to health services due purchasing power, residence underserved areas, inadequate literacy. This produces significant gaps care delivery among a population that has disproportionately large burden of disease. They frequently use the private sector, perceived or actual public services. A subset organizations, some called social enterprises, developed novel approaches increase availability, affordability quality through innovative...

10.1186/1478-4505-8-24 article EN cc-by Health Research Policy and Systems 2010-07-15
Coming Soon ...